Aperio Group, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$1,856,000
+115.6%
24,193
+21.0%
0.01%
+66.7%
Q3 2020$861,000
+25.5%
19,990
+25.8%
0.00%0.0%
Q2 2020$686,000
+25.0%
15,890
-16.7%
0.00%
+50.0%
Q1 2020$549,000
-69.9%
19,066
-33.6%
0.00%
-71.4%
Q4 2019$1,822,000
+181.2%
28,732
+25.0%
0.01%
+133.3%
Q3 2019$648,000
+34.2%
22,993
+26.1%
0.00%
+50.0%
Q2 2019$483,00018,2340.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders